Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and p53 in Gastric Adenocarcinoma: A Pilot Study from Northern India

INTRODUCTION: After the recent approval of Trastuzumab (anti-HER2 antibody) for the treatment of HER2 overexpressed Gastric Adenocarcinoma (GA), importance of HER2 testing is increasingly recognized. However, there is paucity of studies for HER2 overexpression in the Indian patients of GA. Similarly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Diagn Res
Autors principals: Patne, Shashikant C.U., Abhilash, VB, Dixit, Vinod Kumar, Katiyar, Richa, Kumar, Sandip, Singh, Gyan Prakash
Format: Artigo
Idioma:Inglês
Publicat: JCDR Research and Publications (P) Limited 2017
Matèries:
Pathology Section
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483674/
https://ncbi.nlm.nih.gov/pubmed/28658772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/25650.9921
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars